Citadel Advisors’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-32,837
Closed -$31K 14993
2021
Q3
$31K Buy
+32,837
New +$34.5K ﹤0.01% 13564

Other funds holding HIPO.WS

Citadel Advisors's HIPO.WS Position: Q4 2021 in Review

Citadel Advisors sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q4 2021, closing a stake of 32,837 shares — an estimated $31K sold.

Citadel Advisors first reported a position in HIPO.WS in Q3 2021 and held it in 1 quarter. The position peaked at $31K in Q3 2021. 23 funds tracked by Wall St. Rank hold HIPO.WS as of Q4 2021.

  • Citadel Advisors reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q4 2021 after selling out during the quarter.
  • Citadel Advisors sold 32,837 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q4 2021, an estimated $31K.
  • Citadel Advisors first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 1 quarter.
  • Citadel Advisors's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $31K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.